investigations of the intraerythrocyte glutamic oxalacetic transaminases showed , that the action of pyridoxine therapy on the endogenous oxalic acid synthesis can be explained by an increase of available pyridoxal-5-phosphate , the active metabolite of vitamin b6 .
C0034266
pyridoxal-5-phosphate
C0087162
vitamin b6